Devbarna Sinha
Overview
Explore the profile of Devbarna Sinha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wong S, Raleigh J, Callahan J, Vergara I, Ftouni S, Hatzimihalis A, et al.
JCO Precis Oncol
. 2022 Feb;
1:1-14.
PMID: 35172485
Purpose: Circulating tumor DNA (ctDNA) allows noninvasive disease monitoring across a range of malignancies. In metastatic melanoma, the extent to which ctDNA reflects changes in metabolic disease burden assessed by...
2.
Sinha D, Pieterse Z, Kaur P
Bio Protoc
. 2021 Aug;
8(18):e3020.
PMID: 34395808
Bioluminescence imaging (BLI) technology is an advanced method of carrying out molecular imaging on live laboratory animals . This powerful technique is widely-used in studying a variety of biological processes,...
3.
Pieterse Z, Sinha D, Kaur P
Adv Exp Med Biol
. 2019 Jun;
1147:125-135.
PMID: 31147875
Pericytes have long been known to contribute indirectly to tumour growth by regulating angiogenesis. Thus, remodelling tumour blood vessels to maintain blood supply is critical for continued tumour growth. A...
4.
Yeh P, Hunter T, Sinha D, Ftouni S, Wallach E, Jiang D, et al.
Nat Commun
. 2017 Mar;
8:14756.
PMID: 28303898
Several novel therapeutics are poised to change the natural history of chronic lymphocytic leukaemia (CLL) and the increasing use of these therapies has highlighted limitations of traditional disease monitoring methods....
5.
Yeh P, Dickinson M, Ftouni S, Hunter T, Sinha D, Wong S, et al.
Blood
. 2017 Jan;
129(12):1685-1690.
PMID: 28126926
The diagnosis and monitoring of myelodysplastic syndromes (MDSs) are highly reliant on bone marrow morphology, which is associated with substantial interobserver variability. Although azacitidine is the mainstay of treatment in...
6.
Sinha D, Chong L, George J, Schluter H, Monchgesang S, Mills S, et al.
Clin Cancer Res
. 2015 Nov;
22(7):1813-24.
PMID: 26589433
Purpose: The aim of this study was to investigate the role of pericytes in regulating malignant ovarian cancer progression. Experimental Design: The pericyte mRNA signature was used to interrogate ovarian...
7.
Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al.
Nature
. 2015 Sep;
525(7570):538-42.
PMID: 26367796
Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks. Early clinical trials...
8.
Schluter H, Stark H, Sinha D, Boukamp P, Kaur P
J Invest Dermatol
. 2013 Jan;
133(6):1669-73.
PMID: 23358094
No abstract available.